Week of November 11, 2024

This episode discusses four MMWR reports. First, nirsevimab reduces the risk of severe RSV among Alaskan Native children, who have historically experienced high rates of RSV-associated hospitalizations. Second, a concerning decline in the use of antivirals is seen among children and teens hospitalized with flu. Third, measles cases are surging worldwide as vaccination coverage remains below pre-pandemic levels. Last, disease presentation, vaccination status, and recent international travel are important when suspected measles cases occur.